Although bacterial and human FASN share very little sequence homology, TCS was found a decade ago to also inhibit the enoyl reductase partial activity of human FASN and to block growth of the breast cancer cell lines MCF-7 and SKBr-3 at concentrations in the low micromolar range [8]. This evidence concerns the gene FASN and breast carcinoma.